Monday, August 31, 2026

EUR/CHF Jumps By 1% In The Last 21 Sessions

EUR/CHF Jumps By 1% In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.51% for the last 21 sessions. At 22:06 EST on Thursday, 28 March, EUR/CHF (EURCHF) is $0.97.

EUR/CHF's yearly highs and lows, it's 7.663% up from its 52-week low and 2.683% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.03%, a positive 0.10%, and a positive 0.23%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.40% (last week), 0.24% (last month), and 0.23% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy: another leg higher needed for actual FX intervention to be deployed – ING. According to FXStreet on Wednesday, 27 March, "This may still be only a 'verbal intervention' range, with another USD/JPY leg higher needed for actual FX intervention to be deployed (perhaps closer to 155.00). "
  • Usd/jpy: the next major technical resistance after the 151.95-152.00 zone is not before 160.00 – BBH. According to FXStreet on Wednesday, 27 March, "In our view, it's only a matter of time before USD/JPY breaks higher because we anticipate a gradual BoJ tightening process and a more muted than currently priced-in Fed easing cycle.", "The next major technical resistance for USD/JPY after the 151.95-152.00 zone is not before 160.00 (April 1990 high)."
  • According to FXStreet on Wednesday, 27 March, "The Japanese Yen (JPY) continued to weaken against the US Dollar (USD), with USD/JPY reaching its highest level since 1990 near 152.00 early Wednesday. ", "After coming within a few pips of 152.00, USD/JPY edged slightly lower but stabilized above 151.50."
  • According to FXStreet on Thursday, 28 March, "This further contributes to keeping a lid on any meaningful appreciating move for the USD/JPY pair ahead of the release of the US Personal Consumption Expenditures (PCE) Price Index on Friday. ", "This is closely followed by the 150.00 psychological mark, which, if broken decisively, could make the USD/JPY pair vulnerable to accelerate the corrective decline further towards the 149.35-149.30 region en route to the 149.00 round figure."
  • Usd/jpy analysis: strong move ahead - 27 March 2024. According to DailyForex on Wednesday, 27 March, "Overall, according to economic calendar data, USD/JPY could take cues from medium-to-high US data, including the core PCE inflation index due later in the week. ", "There is no change in our technical view, as the overall trend for the USD/JPY currency pair remains bullish, and there will be no trend break without moving towards support levels at 149.80 and 148.00 respectively. "

More news about EUR/CHF (EURCHF).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com